Evidence map›Paper›PMID 37989612›Full record

ArticleVaccine2023

Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo.

Patrick Banza Mpiongo, Jerry Kibanza, Francis Kambol Yav, Didier Nyombo, Lucie Mwepu, Djogo Basame, Raoul Mpoyi, Collard Madika, Trad Hatton, Eric Mafuta and 16 more

Open access · hybridAbstract read
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 3 countries.

Patrick Banza MpiongoProvincial Division of Health, Ministry of Health, Haut Lomami, Democratic Republic of the Congo.
Jerry KibanzaProvincial Division of Health, Ministry of Health, Tanganyika, Democratic Republic of the Congo.
Francis Kambol YavProvincial Division of Health, Ministry of Health, Lualaba, Democratic Republic of the Congo.
Didier NyomboMcKing Consulting, Kinshasa, Democratic Republic of the Congo.
Lucie MwepuMcKing Consulting, Kinshasa, Democratic Republic of the Congo.
Djogo BasameMcKing Consulting, Kinshasa, Democratic Republic of the Congo.
Raoul MpoyiMcKing Consulting, Kinshasa, Democratic Republic of the Congo. Electronic address: raoulmpoy@yahoo.fr.
Collard MadikaMcKing Consulting, Kinshasa, Democratic Republic of the Congo.
Trad HattonPATH, Kinshasa, Democratic Republic of the Congo. Electronic address: thatton@path.org.
Eric MafutaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Oriane GasconIndependent Consultant.
Kevin TschirhartGRID3, Columbia University, NY, USA. Electronic address: ktschirh@ciesin.columbia.edu.
Freddy NkosiVillageReach RDC, Kinshasa, Democratic Republic of the Congo. Electronic address: freddy.nkosi@villagereach.org.
Paul LusambaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Sydney MerrittDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA. Electronic address: sydneymerritt@g.ucla.edu.
Julio MwendaPATH, Kinshasa, Democratic Republic of the Congo. Electronic address: JMwenda@path.org.
Sylvia TangneyDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA. Electronic address: stangney@g.ucla.edu.
Nicole A HoffDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA. Electronic address: nhoff84@ucla.edu.
Dalau Nkamba MukadiKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo. Electronic address: dalau.nkamba@unikin.ac.cd.
Anne W RimoinDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA. Electronic address: arimoin@ucla.edu.
Didine KabaKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo. Electronic address: didine.kaba@unikin.ac.cd.
Amine El MouridBill and Melinda Gates Foundation, Seattle, WA, USA. Electronic address: amine.elmourid@gatesfoundation.org.
Kamel SenouciUniversity of Geneva, Geneva, Switzerland. Electronic address: kamel.senouci@developmentcatalysts.org.
Guillaume Ngoie MwambaVillageReach RDC, Kinshasa, Democratic Republic of the Congo. Electronic address: guillaume.mwamba@villagereach.org.
Elisabeth Mukamba MusengaExpanded Programme for Immunization, Minister of Health, Kinshasa, Democratic Republic of the Congo.
Aimé CikomolaExpanded Programme for Immunization, Minister of Health, Kinshasa, Democratic Republic of the Congo.
Ministry of Public Health · CDUniversity of California, Los Angeles · USVillageReach · USColumbia University · USGates Foundation · USKinshasa General Hospital · CDUniversity of Geneva · CHUniversity of Kinshasa · CD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow immunization coverage rates in the Democratic Republic of Congo (DRC) have been reflective of challenges with vaccine access, support and delivery in the country. Motivated by measles and vaccine-derived polio virus (VDPV) outbreaks in 2016-17 and low vaccination rates, the provinces of Haut Lomami and Tanganyika were identified as pilot locations for an innovative approach focused on establishing a consortium of partners supporting local government. This approach was formalized through Memorandums of Understanding (MoUs) between the Bill and Melinda Gates Foundation and Provincial governments in 2018. A third province, Lualaba, established an MoU in 2021. MOU IMPLEMENTATION: These MoUs were 5-year partnerships designed to aid provinces in meeting four key objectives: 80 % immunization coverage, management/elimination of polio/cVDPV outbreaks, improvement of vaccine accessibility, and transfer of immunization service management to provincial leadership. OUTCOMES: During the MoU period, Haut-Lomami saw an increase in full immunization coverage, from 35.7 % (MICS 2018) to 88.9 % (VCS 2021-22), the highest in country. A sharp drop in percentage of zero-dose children was observed in the 3 provinces, confirming improved access to immunization services. Tanganyika saw initial improvement in full immunization coverage, followed by a drop in the VCS 2021-22 due to COVID-19 and healthcare worker strikes. Coverage improved in Tanganyika in the 2023 VCS. The 3 provinces increased their financial contributions to routine immunization and are now the top contributing provinces. While no cVDPV cases were recorded in 2020 and 2021, cVDPV1 and cVDPV2 outbreaks are afflicting the 3 provinces since 2022.

conclusionsUltimately, the provincial MoUs were successful in bolstering provincial autonomy and capacity building with the biggest success being a drop in zero-dose children. While not all objectives have been met, the MoU approach served as an innovative program for key aspects of strengthening routine immunization in the DRC.

Indexed as

PoliomyelitisVaccinesChildDemocratic Republic of the CongoHumansImmunizationImmunization ProgramsPublic-Private Sector PartnershipsVaccinationVaccinesDRCMemorandums of understandingProvincial autonomyRoutine immunizationVaccine

Identifiers

PMID37989612
PMCPMC10711503
OpenAlexW4388806471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.